speb/financial-data huggingface dataset:
DuPont ROE decomposition for CALM (annual period ending 2022-05-31)
ROE: 12.011644911689736%
Net margin: 7.464160494362069%
Asset turnover: 1.2449546021020126
Equity multiplier (leverage): 1.2926114574702652
EBIT margin: 7.789286158413512%
Interest burden factor: 1.1992877163579623
Tax burden factor: 0.799024184561636
ROE archetype: Standard Business
DuPont ROE decomposition for CALM (annual period ending 2023-05-31)
ROE: 55.861761992212024%
Net margin: 24.09318874063677%
Asset turnover: 1.860558235418304
Equity multiplier (leverage): 1.2461693899027535
EBIT margin: 30.647917800965413%
Interest burden factor: 1.0355716878402903
Tax burden factor: 0.7591247308597466
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CALM (annual period ending 2024-05-31)
ROE: 16.31455874522181%
Net margin: 11.944758586391329%
Asset turnover: 1.1240793702102247
Equity multiplier (leverage): 1.2150691035646415
EBIT margin: 13.264627588124874%
Interest burden factor: 1.166487358795051
Tax burden factor: 0.7719732978489934
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CALM (annual period ending 2025-05-31)
ROE: 55.926279228926134%
Net margin: 28.626957320528355%
Asset turnover: 1.6176039685883348
Equity multiplier (leverage): 1.2077263240598681
EBIT margin: 36.050620793381334%
Interest burden factor: 1.043416061586685
Tax burden factor: 0.7610355165044643
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CAR.AX (annual period ending 2022-06-30)
ROE: 15.931770884213577%
Net margin: 31.71504507176714%
Asset turnover: 0.27353304494021596
Equity multiplier (leverage): 1.8364914856686687
EBIT margin: 43.85348385411244%
Interest burden factor: 1.000994409804343
Tax burden factor: 0.7224862397637267
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CAR.AX (annual period ending 2023-06-30)
ROE: 31.02015871532845%
Net margin: 82.98606311025094%
Asset turnover: 0.2359236469220988
Equity multiplier (leverage): 1.5844092916612789
EBIT margin: 37.548832875085125%
Interest burden factor: 2.385225587618674
Tax burden factor: 0.9265721872704354
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CAR.AX (annual period ending 2024-06-30)
ROE: 8.643407164996528%
Net margin: 23.758104856178623%
Asset turnover: 0.23572280414073735
Equity multiplier (leverage): 1.5433754161326034
EBIT margin: 37.596521055333284%
Interest burden factor: 0.8343670264015377
Tax burden factor: 0.7573680881559325
ROE archetype: Standard Business
DuPont ROE decomposition for CAR.AX (annual period ending 2025-06-30)
ROE: 9.692999269470427%
Net margin: 24.74980065143058%
Asset turnover: 0.24531569988526328
Equity multiplier (leverage): 1.5964713581667072
EBIT margin: 37.922264194293895%
Interest burden factor: 0.8332468342447293
Tax burden factor: 0.7832560775444956
ROE archetype: Standard Business
DuPont ROE decomposition for CARE (quarterly period ending 2025-03-31)
ROE: 2.2284115629495775%
Net margin: 24.837018337170917%
Asset turnover: 0.007669106163091743
Equity multiplier (leverage): 11.699066123066661
Tax burden factor: 0.8039691091954023
ROE archetype: Low Return
DuPont ROE decomposition for CARE (quarterly period ending 2025-06-30)
ROE: 2.107998379987144%
Net margin: 23.459036277428602%
Asset turnover: 0.007649631847233419
Equity multiplier (leverage): 11.746799917265399
Tax burden factor: 0.8007150922092585
ROE archetype: Low Return
DuPont ROE decomposition for CARE (quarterly period ending 2025-09-30)
ROE: 1.3241731859206107%
Net margin: 14.211906635195385%
Asset turnover: 0.007923767249467749
Equity multiplier (leverage): 11.758738528943532
Tax burden factor: 0.7574783337992731
ROE archetype: Low Return
DuPont ROE decomposition for CARE (quarterly period ending 2025-12-31)
ROE: 2.099851657888257%
Net margin: 22.657404287306566%
Asset turnover: 0.007960965084650384
Equity multiplier (leverage): 11.641601854576685
Tax burden factor: 0.7886853739962104
ROE archetype: Low Return
DuPont ROE decomposition for CARE (quarterly period ending 2026-03-31)
ROE: 18.55009577124786%
Net margin: 80.97387330393647%
Asset turnover: 0.021946926348579532
Equity multiplier (leverage): 10.438246201866972
Tax burden factor: 0.7793894447928311
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CARERATING.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.172121617195977
ROE archetype: Standard Business
DuPont ROE decomposition for CARERATING.NS (quarterly period ending 2025-03-31)
ROE: 5.440126031655344%
Net margin: 39.554714097193916%
Asset turnover: 0.11722015925475557
Equity multiplier (leverage): 1.1732981996987826
EBIT margin: 40.408149864707%
Interest burden factor: 1.3290000203124046
Tax burden factor: 0.7365534973134166
ROE archetype: Standard Business
DuPont ROE decomposition for CARERATING.NS (quarterly period ending 2025-06-30)
Net margin: 28.217240828496887%
EBIT margin: 25.9217294073798%
Interest burden factor: 1.5380908560583029
Tax burden factor: 0.707731591163438
ROE archetype: Standard Business
DuPont ROE decomposition for CARERATING.NS (quarterly period ending 2025-09-30)
ROE: 6.555408249905753%
Net margin: 41.951630514089864%
Asset turnover: 0.13144318966491075
Equity multiplier (leverage): 1.1888109836796288
EBIT margin: 47.62629325421589%
Interest burden factor: 1.1841828525678035
Tax burden factor: 0.7438464508931765
ROE archetype: Standard Business
DuPont ROE decomposition for CARERATING.NS (quarterly period ending 2025-12-31)
Net margin: 32.58850453336568%
EBIT margin: 32.68750189521977%
Interest burden factor: 1.3367802982761539
Tax burden factor: 0.7458004890414706
ROE archetype: Standard Business
DuPont ROE decomposition for CARERATING.NS (quarterly period ending 2026-03-31)
ROE: 5.667180313619053%
Net margin: 40.90346605688677%
Asset turnover: 0.1182816362627485
Equity multiplier (leverage): 1.171357861221168
EBIT margin: 43.5654369285705%
Interest burden factor: 1.2649305250584082
Tax burden factor: 0.7422519778860054
ROE archetype: Standard Business
DuPont ROE decomposition for CARG (annual period ending 2022-12-31)
ROE: 25.122576028251476%
Net margin: 11.708815825647191%
Asset turnover: 1.7851703480307453
Equity multiplier (leverage): 1.2019088412902958
EBIT margin: 6.554423320352742%
Interest burden factor: 1.0265860358782426
Tax burden factor: 1.7401357734236096
ROE archetype: Asset-Light Turnover Play
DuPont ROE decomposition for CARG (annual period ending 2023-12-31)
ROE: 5.3222495155632075%
Net margin: 5.289359856018075%
Asset turnover: 0.756673920073845
Equity multiplier (leverage): 1.3297908817830155
EBIT margin: 17.228720213166557%
Interest burden factor: 1.1562383132910603
Tax burden factor: 0.2655233632096831
ROE archetype: Standard Business
DuPont ROE decomposition for CARG (annual period ending 2024-12-31)
ROE: 3.620415677994995%
Net margin: 2.6279252773030057%
Asset turnover: 0.915469958353002
Equity multiplier (leverage): 1.5048781182539073
EBIT margin: 21.164747808391517%
Interest burden factor: 0.9969331691374982
Tax burden factor: 0.12454717138004347
ROE archetype: Low Return
DuPont ROE decomposition for CARG (annual period ending 2025-12-31)
ROE: 34.04415610222659%
Net margin: 17.189243423228735%
Asset turnover: 1.2203442738421442
Equity multiplier (leverage): 1.6229436600803375
EBIT margin: 27.006549207259255%
Interest burden factor: 1.0322114442484813
Tax burden factor: 0.6166219733105516
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CARTRADE.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.154237586731791
ROE archetype: Standard Business
DuPont ROE decomposition for CARTRADE.NS (quarterly period ending 2024-12-31)
Net margin: 25.83985281649618%
EBIT margin: 22.45348590418318%
Interest burden factor: 1.349325818558629
Tax burden factor: 0.8528829458250059
ROE archetype: Standard Business
DuPont ROE decomposition for CARTRADE.NS (quarterly period ending 2025-03-31)
ROE: 1.9818174151576728%
Net margin: 27.19955543442481%
Asset turnover: 0.06266130738624627
Equity multiplier (leverage): 1.162792930791473
EBIT margin: 21.545148536579322%
Interest burden factor: 1.4603088549367504
Tax burden factor: 0.8645051693685384
ROE archetype: Low Return
DuPont ROE decomposition for CARTRADE.NS (quarterly period ending 2025-06-30)
Net margin: 27.19792047720841%
EBIT margin: 19.92392497213067%
Interest burden factor: 1.650774590080722
Tax burden factor: 0.826938147264402
ROE archetype: Standard Business
DuPont ROE decomposition for CARTRADE.NS (quarterly period ending 2025-12-31)
Net margin: 29.342524841204202%
EBIT margin: 32.84890958154602%
Interest burden factor: 1.1323849472013754
Tax burden factor: 0.788828213850235
ROE archetype: Standard Business
DuPont ROE decomposition for CARTRADE.NS (quarterly period ending 2026-03-31)
ROE: 2.7056560883181557%
Net margin: 34.87482469254432%
Asset turnover: 0.06750743612271969
Equity multiplier (leverage): 1.1492352698080948
EBIT margin: 29.896855960158135%
Interest burden factor: 1.2348872284443155
Tax burden factor: 0.9446245211596437
ROE archetype: Low Return
DuPont ROE decomposition for CASH.MC (quarterly period ending 2025-03-31)
ROE: 8.61070911722141%
Net margin: 4.611509397403603%
Asset turnover: 0.2120900797238432
Equity multiplier (leverage): 8.803907380607805
Tax burden factor: 0.5483870967741936
ROE archetype: Standard Business
DuPont ROE decomposition for CASH.MC (quarterly period ending 2025-06-30)
ROE: 10.966899887200542%
Net margin: 4.859558891195206%
Asset turnover: 0.2078464317949636
Equity multiplier (leverage): 10.857865466763283
Tax burden factor: 0.5490019406709177
ROE archetype: Standard Business
DuPont ROE decomposition for CASH.MC (quarterly period ending 2025-09-30)
ROE: 10.262837981719136%
Net margin: 3.940551225923971%
Asset turnover: 0.19684027968061762
Equity multiplier (leverage): 13.231117364665797
Tax burden factor: 0.5696971510653579
ROE archetype: Standard Business
DuPont ROE decomposition for CASH.MC (quarterly period ending 2025-12-31)
ROE: 22.50668112630234%
Net margin: 4.732884424689026%
Asset turnover: 0.37795958527470863
Equity multiplier (leverage): 12.581725183004767
EBIT margin: 10.146869279621761%
Interest burden factor: 0.8266710814119158
Tax burden factor: 0.5642363850420555
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CASH.MC (quarterly period ending 2026-03-31)
ROE: 9.932954144809331%
Net margin: 5.1880152825256385%
Asset turnover: 0.1945818292499647
Equity multiplier (leverage): 9.839542411041855
Tax burden factor: 0.581081081081081
ROE archetype: Standard Business
DuPont ROE decomposition for CASS (quarterly period ending 2025-03-31)
ROE: 3.827583704380419%
Net margin: 18.95079472438282%
Asset turnover: 0.020406675646777145
Equity multiplier (leverage): 9.897488548412573
Tax burden factor: 0.8243081732095247
ROE archetype: Low Return
DuPont ROE decomposition for CASS (quarterly period ending 2025-06-30)
ROE: 3.727879529078934%
Net margin: 19.93336784998762%
Asset turnover: 0.019170671974711267
Equity multiplier (leverage): 9.755372377486218
Tax burden factor: 1.4102564102564104
ROE archetype: Low Return
DuPont ROE decomposition for CASS (quarterly period ending 2025-09-30)
ROE: 3.7607042337864542%
Net margin: 18.26203798407637%
Asset turnover: 0.02090849623870984
Equity multiplier (leverage): 9.84911340964047
Tax burden factor: 0.7839862247094275
ROE archetype: Low Return
DuPont ROE decomposition for CASS (quarterly period ending 2025-12-31)
ROE: 3.3668621658680182%
Net margin: 20.487865899424566%
Asset turnover: 0.015799524314546908
Equity multiplier (leverage): 10.401227677424263
Tax burden factor: 0.8198017819601562
ROE archetype: Low Return
DuPont ROE decomposition for CASS (quarterly period ending 2026-03-31)
ROE: 3.643639514016378%
Net margin: 17.965094992067044%
Asset turnover: 0.01912987140587745
Equity multiplier (leverage): 10.602147321520658
Tax burden factor: 0.8115409354038409
ROE archetype: Low Return
DuPont ROE decomposition for CAT1.DE (quarterly period ending 2025-03-31)
ROE: 11.084670724958496%
Net margin: 14.057126815916906%
Asset turnover: 0.16768658648527784
Equity multiplier (leverage): 4.702490315439956
EBIT margin: 18.099515755491613%
Interest burden factor: 0.9965102753005041
Tax burden factor: 0.7793774319066148
ROE archetype: Standard Business
DuPont ROE decomposition for CAT1.DE (quarterly period ending 2025-06-30)
ROE: 11.863991506275012%
Net margin: 13.151065242319996%
Asset turnover: 0.18903701675423135
Equity multiplier (leverage): 4.772248387008957
EBIT margin: 17.26115034099825%
Interest burden factor: 0.9853146853146854
Tax burden factor: 0.7732434350603264
ROE archetype: Standard Business
DuPont ROE decomposition for CAT1.DE (quarterly period ending 2025-09-30)
ROE: 11.69828594679823%
Net margin: 13.040027213969838%
Asset turnover: 0.19166843251995413
Equity multiplier (leverage): 4.680509638370378
EBIT margin: 17.303549155233018%
Interest burden factor: 1.0245740498034075
Tax burden factor: 0.7355292612727854
ROE archetype: Standard Business
DuPont ROE decomposition for CAT1.DE (quarterly period ending 2025-12-31)
ROE: 11.444362388927269%
Net margin: 12.554225683374277%
Asset turnover: 0.19898391634209883
Equity multiplier (leverage): 4.5812468732877525
EBIT margin: 13.902681231380337%
Interest burden factor: 1.137593984962406
Tax burden factor: 0.7937871777924653
ROE archetype: Standard Business
DuPont ROE decomposition for CAT1.DE (quarterly period ending 2026-03-31)
ROE: 12.752013607484116%
Net margin: 14.636807349985645%
Asset turnover: 0.1794112344502537
Equity multiplier (leverage): 4.8560458252038625
EBIT margin: 17.714613838644848%
Interest burden factor: 1.0408427876823338
Tax burden factor: 0.7938336966677048
ROE archetype: Standard Business
DuPont ROE decomposition for CAT31.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 8.050616475149074
ROE archetype: Standard Business
DuPont ROE decomposition for CAT31.PA (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 7.876071535003962
ROE archetype: Standard Business
DuPont ROE decomposition for CAT31.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 7.551263978970825
ROE archetype: Standard Business
DuPont ROE decomposition for CAVA (quarterly period ending 2025-03-31)
ROE: 3.5400606466218845%
Net margin: 7.7471325333156535%
Asset turnover: 0.27013675924787706
Equity multiplier (leverage): 1.6915546411741538
EBIT margin: 6.587187260793308%
Interest burden factor: 0.9311922408271571
Tax burden factor: 1.2629949887000098
ROE archetype: Low Return
DuPont ROE decomposition for CAVA (quarterly period ending 2025-06-30)
ROE: 2.487400829991272%
Net margin: 6.545623006610481%
Asset turnover: 0.2227105825919634
Equity multiplier (leverage): 1.7062942697559658
EBIT margin: 9.199436950982664%
Interest burden factor: 0.9180708890180128
Tax burden factor: 0.7750210970464135
ROE archetype: Low Return
DuPont ROE decomposition for CAVA (quarterly period ending 2025-09-30)
ROE: 1.9407484127041574%
Net margin: 5.0462294431251244%
Asset turnover: 0.2236275990362766
Equity multiplier (leverage): 1.7197956469698754
EBIT margin: 7.952080153847206%
Interest burden factor: 0.8892809501269417
Tax burden factor: 0.7135875350817769
ROE archetype: Low Return
DuPont ROE decomposition for CAVA (quarterly period ending 2025-12-31)
ROE: 0.6355130531359167%
Net margin: 1.789552157390403%
Asset turnover: 0.20505919822699875
Equity multiplier (leverage): 1.731812458432074
EBIT margin: 3.066349073585832%
Interest burden factor: 0.7209440227703985
Tax burden factor: 0.8095081427866425
ROE archetype: Low Return
DuPont ROE decomposition for CAVA (quarterly period ending 2026-03-31)
Net margin: 5.377050676523605%
EBIT margin: 7.788805987176854%
Interest burden factor: 0.8799800796812749
Tax burden factor: 0.7845134658277573
ROE archetype: Standard Business
DuPont ROE decomposition for CAVA (quarterly period ending 2026-04-30)
Equity multiplier (leverage): 1.7567737076681853
ROE archetype: Standard Business
DuPont ROE decomposition for CBA.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.2267169508118967
ROE archetype: Standard Business
DuPont ROE decomposition for CBA.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.2327852337151382
ROE archetype: Standard Business
DuPont ROE decomposition for CBAN (quarterly period ending 2025-03-31)
ROE: 2.3047834800034854%
Net margin: 22.046272836378183%
Asset turnover: 0.0094570160711893
Equity multiplier (leverage): 11.054543870349395
Tax burden factor: 0.799154078549849
ROE archetype: Low Return
DuPont ROE decomposition for CBAN (quarterly period ending 2025-06-30)
ROE: 2.747330323598183%
Net margin: 24.56053935904935%
Asset turnover: 0.010332659927519014
Equity multiplier (leverage): 10.82582104817298
Tax burden factor: 0.7954930700967195
ROE archetype: Low Return
DuPont ROE decomposition for CBAN (quarterly period ending 2025-09-30)
ROE: 1.9520655362645067%
Net margin: 17.746264104910033%
Asset turnover: 0.010462061625977946
Equity multiplier (leverage): 10.51405342936552
Tax burden factor: 0.7995328386919484
ROE archetype: Low Return
DuPont ROE decomposition for CBAN (quarterly period ending 2025-12-31)
ROE: 2.3127097303067297%
Net margin: 21.247832683138274%
Asset turnover: 0.010717541306827512
Equity multiplier (leverage): 10.15573415190814
Tax burden factor: 0.8209986391709411
ROE archetype: Low Return
DuPont ROE decomposition for CBAN (quarterly period ending 2026-03-31)
ROE: 2.1694434785138097%
Net margin: 20.56398044867778%
Asset turnover: 0.010701428403970271
Equity multiplier (leverage): 9.858240460755523
Tax burden factor: 0.7834972781969248
ROE archetype: Low Return
DuPont ROE decomposition for CBG.L (quarterly period ending 2025-01-31)
Equity multiplier (leverage): 8.439936867948793
ROE archetype: Standard Business
DuPont ROE decomposition for CBG.L (quarterly period ending 2026-01-31)
Equity multiplier (leverage): 7.893374718573087
ROE archetype: Standard Business
DuPont ROE decomposition for CBLU.V (quarterly period ending 2024-09-30)
Net margin: -426.9804520480805%
Asset turnover: 0.03154635275754778
EBIT margin: -315.67031413740165%
ROE archetype: Standard Business
DuPont ROE decomposition for CBLU.V (quarterly period ending 2024-12-31)
Net margin: -1235.034953292503%
Asset turnover: 0.06210803463712474
EBIT margin: -137.63130683776546%
ROE archetype: Standard Business
DuPont ROE decomposition for CBLU.V (quarterly period ending 2025-03-31)
Net margin: -1.8607177475431886%
Asset turnover: 0.18247974929931546
EBIT margin: -38.133251399985355%
ROE archetype: Standard Business
DuPont ROE decomposition for CBLU.V (quarterly period ending 2025-06-30)
Net margin: -32.216780306103374%
Asset turnover: 0.21207547097956087
EBIT margin: -44.2243182515635%
ROE archetype: Standard Business
DuPont ROE decomposition for CBLU.V (quarterly period ending 2025-09-30)
Net margin: -82.75263844221844%
Asset turnover: 0.169495160787209
EBIT margin: -53.36016151417442%
ROE archetype: Standard Business
DuPont ROE decomposition for CBLU.V (quarterly period ending 2025-12-31)
Net margin: -2499.642379833172%
Asset turnover: 0.02037790014705221
EBIT margin: -1356.3454537075443%
ROE archetype: Standard Business
DuPont ROE decomposition for CBLU.V (quarterly period ending 2026-03-31)
Net margin: -41.64588825952114%
Asset turnover: 0.20993739497686115
EBIT margin: -14.129879779944252%
ROE archetype: Standard Business
DuPont ROE decomposition for CBR.V (quarterly period ending 2024-09-30)
ROE: -43.5657377482209%
Asset turnover: 0
Equity multiplier (leverage): 1.157026321514031
ROE archetype: Low Return
DuPont ROE decomposition for CBR.V (quarterly period ending 2024-12-31)
ROE: -29.196947297391677%
Asset turnover: 0
Equity multiplier (leverage): 1.1313748188773567
ROE archetype: Low Return
DuPont ROE decomposition for CBR.V (quarterly period ending 2025-03-31)
ROE: -47.13127984194392%
Asset turnover: 0
Equity multiplier (leverage): 1.146499368957025
ROE archetype: Low Return
DuPont ROE decomposition for CBR.V (quarterly period ending 2025-06-30)
ROE: -29.35954671510736%
Asset turnover: 0
Equity multiplier (leverage): 1.1177032969965206
ROE archetype: Low Return
DuPont ROE decomposition for CBR.V (quarterly period ending 2025-12-31)
ROE: -167.9212158953394%
Asset turnover: 0
Equity multiplier (leverage): 4.929669634180622
ROE archetype: Low Return
DuPont ROE decomposition for CBR.V (quarterly period ending 2026-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CBSH (annual period ending 2022-12-31)
ROE: 20.149284104422307%
Net margin: 33.13088960831578%
Asset turnover: 0.04734688376631258
Equity multiplier (leverage): 12.845029995039445
Tax burden factor: 0.7906979686200343
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CBSH (annual period ending 2023-12-31)
ROE: 17.818369251793168%
Net margin: 30.588169281894185%
Asset turnover: 0.0498972647211746
Equity multiplier (leverage): 11.67448497532138
Tax burden factor: 0.7828895350525877
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CBSH (annual period ending 2024-12-31)
ROE: 16.973988776669703%
Net margin: 32.122741824765484%
Asset turnover: 0.05223492570091398
Equity multiplier (leverage): 10.116034973847434
Tax burden factor: 0.7864736787885032
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CBSH (annual period ending 2025-12-31)
ROE: 15.969757306554538%
Net margin: 32.28302538919866%
Asset turnover: 0.0544677943809096
Equity multiplier (leverage): 9.082058588432721
Tax burden factor: 0.7798192215458403
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CBT (quarterly period ending 2025-03-31)
ROE: 6.60377358490566%
Net margin: 11.217948717948719%
Asset turnover: 0.24735729386892177
Equity multiplier (leverage): 2.379874213836478
EBIT margin: 17.307692307692307%
Interest burden factor: 0.9320987654320988
Tax burden factor: 0.695364238410596
ROE archetype: Standard Business
DuPont ROE decomposition for CBT (quarterly period ending 2025-06-30)
ROE: 6.904980140543844%
Net margin: 12.242686890574214%
Asset turnover: 0.24222542973363076
Equity multiplier (leverage): 2.328444851817904
EBIT margin: 18.0931744312026%
Interest burden factor: 0.9281437125748503
Tax burden factor: 0.7290322580645161
ROE archetype: Standard Business
DuPont ROE decomposition for CBT (quarterly period ending 2025-09-30)
ROE: 3.187721369539551%
Net margin: 6.0066740823136815%
Asset turnover: 0.23497124934657607
Equity multiplier (leverage): 2.258559622195986
EBIT margin: 15.239154616240267%
Interest burden factor: 0.8394160583941606
Tax burden factor: 0.46956521739130436
ROE archetype: Low Return
DuPont ROE decomposition for CBT (quarterly period ending 2025-12-31)
ROE: 4.775771694816541%
Net margin: 9.65842167255595%
Asset turnover: 0.22424722662440572
Equity multiplier (leverage): 2.2050087361677346
EBIT margin: 15.19434628975265%
Interest burden factor: 0.9147286821705426
Tax burden factor: 0.6949152542372882
ROE archetype: Low Return
DuPont ROE decomposition for CBT (quarterly period ending 2026-03-31)
ROE: 4.566744730679157%
Net margin: 8.628318584070795%
Asset turnover: 0.23621635746015154
Equity multiplier (leverage): 2.240632318501171
EBIT margin: 14.269911504424778%
Interest burden factor: 0.9302325581395349
Tax burden factor: 0.65
ROE archetype: Low Return
DuPont ROE decomposition for CCAP (quarterly period ending 2025-03-31)
ROE: 0.5369112748617151%
Net margin: 54.76223874316173%
Asset turnover: 0.004277835483652236
Equity multiplier (leverage): 2.2919083730103065
Tax burden factor: 0.8862656072644722
ROE archetype: Low Return
DuPont ROE decomposition for CCAP (quarterly period ending 2025-06-30)
ROE: 2.068137078654781%
Net margin: 78.38868003341688%
Asset turnover: 0.011534080250145967
Equity multiplier (leverage): 2.287404655340334
Tax burden factor: 0.9740478816583403
ROE archetype: Low Return
DuPont ROE decomposition for CCAP (quarterly period ending 2025-09-30)
ROE: 0.9872177404501418%
Net margin: 72.50638080653394%
Asset turnover: 0.005968790447010304
Equity multiplier (leverage): 2.2811318669633045
Tax burden factor: 0.9619395909521875
ROE archetype: Low Return
DuPont ROE decomposition for CCAP (quarterly period ending 2025-12-31)
ROE: 1.1956794987441142%
Net margin: 74.82153873270468%
Asset turnover: 0.006983278472922487
Equity multiplier (leverage): 2.2883833892091685
Tax burden factor: 0.9443826473859844
ROE archetype: Low Return
DuPont ROE decomposition for CCAP (quarterly period ending 2026-03-31)
ROE: -2.2481533491876475%
Asset turnover: -0.008590682911757524
Equity multiplier (leverage): 2.3475609137534
ROE archetype: Low Return
DuPont ROE decomposition for CCAP.DE (annual period ending 2021-12-31)
ROE: -31.954647077610986%
Net margin: -91.8732782369146%
Asset turnover: 0.1540747028862479
Equity multiplier (leverage): 2.2574257425742577
EBIT margin: 2.7548209366391188%
Interest burden factor: -35.45
ROE archetype: Low Return
DuPont ROE decomposition for CCAP.DE (annual period ending 2022-12-31)
ROE: -271.16520701626473%
Net margin: -1011.9727891156464%
Asset turnover: 0.06804352765925216
Equity multiplier (leverage): 3.938023547737611
EBIT margin: -226.9387755102041%
ROE archetype: Low Return
DuPont ROE decomposition for CCAP.DE (annual period ending 2023-12-31)
Net margin: 539.9509803921568%
Asset turnover: 0.07638851543126886
EBIT margin: -185.0490196078431%
Tax burden factor: 1.0138057984353428
ROE archetype: Standard Business
DuPont ROE decomposition for CCDS.V (annual period ending 2023-06-30)
Net margin: -45.73730133476244%
Asset turnover: 0.1952932849801668
EBIT margin: -38.06903250657333%
ROE archetype: Standard Business
DuPont ROE decomposition for CCDS.V (annual period ending 2024-06-30)
Net margin: -23.43257559588322%
Asset turnover: 0.231461459995815
EBIT margin: -16.738227166010198%
ROE archetype: Standard Business
DuPont ROE decomposition for CCEC.V (quarterly period ending 2024-12-31)
ROE: -42.349019260476595%
Asset turnover: 0
Equity multiplier (leverage): 1.1036459148051052
ROE archetype: Low Return
DuPont ROE decomposition for CCEC.V (quarterly period ending 2025-03-31)
ROE: -27.277616278920853%
Asset turnover: 0
Equity multiplier (leverage): 1.056768422045914
ROE archetype: Low Return
DuPont ROE decomposition for CCEC.V (quarterly period ending 2025-06-30)
ROE: -17.49973700311229%
Asset turnover: 0
Equity multiplier (leverage): 1.0401601941843326
ROE archetype: Low Return
DuPont ROE decomposition for CCEC.V (quarterly period ending 2025-09-30)
ROE: -41.98172704130273%
Asset turnover: 0
Equity multiplier (leverage): 1.0531544321629105
ROE archetype: Low Return
DuPont ROE decomposition for CCEC.V (quarterly period ending 2025-12-31)
ROE: 18.835876309611482%
Asset turnover: 0
Equity multiplier (leverage): 1.0586695617170856
Interest burden factor: 1.1008605515653946
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CCEC.V (quarterly period ending 2026-03-31)
ROE: -10.605587195126784%
Asset turnover: 0
Equity multiplier (leverage): 1.0429128081013481
ROE archetype: Low Return
DuPont ROE decomposition for CCG (quarterly period ending 2024-09-30)
ROE: 1.1435297837145098%
Net margin: 0.47629853371537545%
Asset turnover: 0.7763882283457738
Equity multiplier (leverage): 3.092354638197451
EBIT margin: -0.707452055632045%
Tax burden factor: 1.0227215349659176
ROE archetype: Low Return
DuPont ROE decomposition for CCG (quarterly period ending 2024-12-31)
ROE: -2.874450272948098%
Net margin: -1.0588266391226024%
Asset turnover: 0.8100041609213253
Equity multiplier (leverage): 3.3515267562889437
EBIT margin: -0.26788364801613607%
ROE archetype: Low Return
DuPont ROE decomposition for CCG (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 3.690644905969119
ROE archetype: Standard Business
DuPont ROE decomposition for CCG (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 3.963746225829198
ROE archetype: Standard Business
DuPont ROE decomposition for CCJ (annual period ending 2022-12-31)
ROE: 1.5315456561912866%
Net margin: 4.784895955734546%
Asset turnover: 0.2163845466930575
Equity multiplier (leverage): 1.4792146763272855
EBIT margin: 0.8332427731647113%
Interest burden factor: 5.447799550273048
Tax burden factor: 1.05409517070582
ROE archetype: Low Return
DuPont ROE decomposition for CCJ (annual period ending 2023-12-31)
ROE: 6.137519145952026%
Net margin: 13.944387380891103%
Asset turnover: 0.28261517692434807
Equity multiplier (leverage): 1.557392002765926
EBIT margin: 11.015288137453348%
Interest burden factor: 1.7090149412907956
Tax burden factor: 0.7407262194834067
ROE archetype: Standard Business
DuPont ROE decomposition for CCJ (annual period ending 2024-12-31)
ROE: 2.650722795541098%
Net margin: 5.480404825350823%
Asset turnover: 0.30342898595746653
Equity multiplier (leverage): 1.5940230869143555
EBIT margin: 16.30080248181309%
Interest burden factor: 0.5022263262096112
Tax burden factor: 0.6694284734882127
ROE archetype: Low Return
DuPont ROE decomposition for CCJ (annual period ending 2025-12-31)
ROE: 9.06994371338973%
Net margin: 16.93246251435625%
Asset turnover: 0.3518417159069098
Equity multiplier (leverage): 1.5224293190670142
EBIT margin: 17.842359402090736%
Interest burden factor: 1.2511062213988047
Tax burden factor: 0.7585315614703427
ROE archetype: Standard Business
DuPont ROE decomposition for CCNEP (annual period ending 2022-12-31)
ROE: 11.905147693316403%
Net margin: 28.77099041999053%
Asset turnover: 0.04011266115683158
Equity multiplier (leverage): 10.315695170340001
Tax burden factor: 0.8078860562047715
ROE archetype: Standard Business
DuPont ROE decomposition for CCNEP (annual period ending 2023-12-31)
ROE: 10.529859556500899%
Net margin: 26.597719802511243%
Asset turnover: 0.03885578158298047
Equity multiplier (leverage): 10.188787931858995
Tax burden factor: 0.8077517437246794
ROE archetype: Standard Business
DuPont ROE decomposition for CCNEP (annual period ending 2024-12-31)
ROE: 9.23480170769801%
Net margin: 24.582447479370114%
Asset turnover: 0.03717180633483542
Equity multiplier (leverage): 10.10622094823604
Tax burden factor: 0.810210959188824
ROE archetype: Standard Business
DuPont ROE decomposition for CCNEP (annual period ending 2025-12-31)
ROE: 8.919614087193203%
Net margin: 23.872455941491168%
Asset turnover: 0.037977728263704595
Equity multiplier (leverage): 9.83829819088198
Tax burden factor: 0.8019280907051476
ROE archetype: Standard Business
DuPont ROE decomposition for CCTG (annual period ending 2022-03-31)
ROE: 24.251456152283122%
Net margin: 8.425334841618133%
Asset turnover: 1.6577112218654404
Equity multiplier (leverage): 1.736367999186377
EBIT margin: 9.127143660814793%
Interest burden factor: 1.084338942971701
Tax burden factor: 0.851309006443321
ROE archetype: Asset-Light Turnover Play
DuPont ROE decomposition for CCTG (annual period ending 2023-03-31)
ROE: 22.131717503883397%
Net margin: 9.177858477521365%
Asset turnover: 1.4596237462778248
Equity multiplier (leverage): 1.6520867242255304
EBIT margin: 7.693554278391505%
Interest burden factor: 1.342972985383853
Tax burden factor: 0.888274219695964
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CCTG (annual period ending 2024-03-31)
ROE: -11.379943371023321%
Net margin: -8.781628785092176%
Asset turnover: 0.8567067973097452
Equity multiplier (leverage): 1.5126303620268085
EBIT margin: -12.46857403144214%
ROE archetype: Low Return
DuPont ROE decomposition for CCTG (annual period ending 2025-03-31)
ROE: -12.294187194158827%
Net margin: -7.999693049180362%
Asset turnover: 1.0637859206833864
Equity multiplier (leverage): 1.4446819946412404
EBIT margin: -9.978930310423584%
ROE archetype: Low Return
DuPont ROE decomposition for CCTG (annual period ending 2026-03-31)
ROE: -40.897767520468626%
Net margin: -27.773404033487402%
Asset turnover: 1.0258336793057026
Equity multiplier (leverage): 1.4354680692740116
EBIT margin: -19.98856944308949%
ROE archetype: Low Return
DuPont ROE decomposition for CD3.AX (annual period ending 2022-03-31)
ROE: 35.293565163881354%
Asset turnover: -0.0014023032967620192
Equity multiplier (leverage): 1.0370122922254505
Tax burden factor: 0.9312049902526988
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CD3.AX (annual period ending 2023-03-31)
ROE: 18.236439234468264%
Net margin: 12581.118317241486%
Asset turnover: 0.0013915334302558844
Equity multiplier (leverage): 1.0416627954066593
Tax burden factor: 0.9732853862397994
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CD3.AX (annual period ending 2024-03-31)
ROE: 1.5696429460823509%
Net margin: 364.5972538484777%
Asset turnover: 0.004126825791629656
Equity multiplier (leverage): 1.0432090436831947
Tax burden factor: 1.162651266978286
ROE archetype: Low Return
DuPont ROE decomposition for CD3.AX (annual period ending 2025-03-31)
ROE: 13.963287394430662%
Asset turnover: -0.0012426972135287915
Equity multiplier (leverage): 1.0364742292760412
Tax burden factor: 1.1367436385602825
ROE archetype: Standard Business
DuPont ROE decomposition for CD3.AX (annual period ending 2026-03-31)
ROE: -7.1880224042113845%
Asset turnover: -0.0053827150781813925
Equity multiplier (leverage): 1.0320471845581436
ROE archetype: Low Return
DuPont ROE decomposition for CDFF.L (annual period ending 2022-09-30)
ROE: 8.070575607138068%
Net margin: 342.24751066856334%
Asset turnover: 0.022709652409872078
Equity multiplier (leverage): 1.0383738092043473
EBIT margin: 103.55618776671407%
Interest burden factor: 3.7046703296703294
Tax burden factor: 0.8921023359288099
ROE archetype: Standard Business
DuPont ROE decomposition for CDFF.L (annual period ending 2023-09-30)
ROE: 3.899396655293103%
Net margin: 168.27794561933533%
Asset turnover: 0.02239385751297382
Equity multiplier (leverage): 1.034763980713816
EBIT margin: 100.60422960725074%
Interest burden factor: 1.8948948948948952
Tax burden factor: 0.8827258320126783
ROE archetype: Low Return
DuPont ROE decomposition for CDFF.L (annual period ending 2024-09-30)
ROE: 3.703373379204864%
Net margin: 156.8081991215227%
Asset turnover: 0.02287855302118756
Equity multiplier (leverage): 1.032286338207447
EBIT margin: 87.84773060029283%
Interest burden factor: 2.3083333333333336
Tax burden factor: 0.7732851985559567
ROE archetype: Low Return
DuPont ROE decomposition for CDFF.L (annual period ending 2025-09-30)
ROE: 4.47583903854495%
Net margin: 199.7058823529412%
Asset turnover: 0.021682645571861708
Equity multiplier (leverage): 1.0336448183319116
EBIT margin: 88.97058823529412%
Interest burden factor: 2.7752066115702476
Tax burden factor: 0.8088147706968434
ROE archetype: Low Return
DuPont ROE decomposition for CDGP.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.7875168442974396
ROE archetype: Standard Business
DuPont ROE decomposition for CDGP.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.8068722319806938
ROE archetype: Standard Business
DuPont ROE decomposition for CDGP.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.8713966612833444
ROE archetype: Standard Business
DuPont ROE decomposition for CDLR (quarterly period ending 2025-03-31)
ROE: 0.14671107709430467%
Net margin: 2.7461282341081956%
Asset turnover: 0.02657604762370583
Equity multiplier (leverage): 2.0102575358740404
EBIT margin: 7.376974066041482%
Interest burden factor: 0.6271221532091097
Tax burden factor: 0.593595245955761
ROE archetype: Low Return
DuPont ROE decomposition for CDLR (quarterly period ending 2025-06-30)
ROE: 13.26316636665802%
Net margin: 71.19809835193361%
Asset turnover: 0.09241842460629615
Equity multiplier (leverage): 2.0156738518616915
EBIT margin: 69.9919763495394%
Interest burden factor: 1.0304798803364312
Tax burden factor: 0.9871442509042452
ROE archetype: Standard Business
DuPont ROE decomposition for CDLR (quarterly period ending 2025-09-30)
ROE: 4.587639607414773%
Net margin: 23.528704910750047%
Asset turnover: 0.09428222079669647
Equity multiplier (leverage): 2.068052058331857
EBIT margin: 29.01551951409574%
Interest burden factor: 0.838309300603642
Tax burden factor: 0.9673048997739487
ROE archetype: Low Return
DuPont ROE decomposition for CDLR (quarterly period ending 2025-12-31)
ROE: 3.243485872637783%
Net margin: 28.547046291378475%
Asset turnover: 0.051776852392295195
Equity multiplier (leverage): 2.194396924939976
EBIT margin: 38.85324851255304%
Interest burden factor: 0.767056799680521
Tax burden factor: 0.9578694433319984
ROE archetype: Low Return
DuPont ROE decomposition for CDLR (quarterly period ending 2026-03-31)
ROE: -0.4373739988482236%
Net margin: -5.651542969846144%
Asset turnover: 0.03544315538737523
Equity multiplier (leverage): 2.183501771804278
EBIT margin: 6.242433474708764%
Interest burden factor: -0.8800410994091961
ROE archetype: Low Return
DuPont ROE decomposition for CDM.AX (annual period ending 2021-06-30)
ROE: 11.221090967355057%
Net margin: 68.42410730435795%
Asset turnover: 0.13366426007381924
Equity multiplier (leverage): 1.2269041753399377
Tax burden factor: 0.7072786501025171
ROE archetype: Standard Business
DuPont ROE decomposition for CDM.AX (annual period ending 2022-06-30)
ROE: -0.8421564733692242%
Asset turnover: -0.008513099427891798
Equity multiplier (leverage): 1.2351140518268455
ROE archetype: Low Return
DuPont ROE decomposition for CDM.AX (annual period ending 2023-06-30)
ROE: -2.404933127622849%
Asset turnover: -0.024778297666673072
Equity multiplier (leverage): 1.2470335762870028
ROE archetype: Low Return
DuPont ROE decomposition for CDM.AX (annual period ending 2024-06-30)
ROE: 7.161891716512073%
Net margin: 66.62557291675355%
Asset turnover: 0.08755547055977653
Equity multiplier (leverage): 1.2277318073425583
Tax burden factor: 0.7785535933998927
ROE archetype: Standard Business
DuPont ROE decomposition for CDO.AX (annual period ending 2021-06-30)
Equity multiplier (leverage): 1.1905442252128946
ROE archetype: Standard Business
DuPont ROE decomposition for CDO.AX (annual period ending 2022-06-30)
ROE: -2.6563563381882958%
Asset turnover: -0.026152152934568334
Equity multiplier (leverage): 1.2467542204964788
ROE archetype: Low Return
DuPont ROE decomposition for CDO.AX (annual period ending 2023-06-30)
ROE: -3.9128996876623683%
Asset turnover: -0.03022913545473071
Equity multiplier (leverage): 1.3317620620332853
ROE archetype: Low Return
DuPont ROE decomposition for CDO.AX (annual period ending 2024-06-30)
ROE: 7.252549595019403%
Net margin: 61.69146426641715%
Asset turnover: 0.09304388319806296
Equity multiplier (leverage): 1.2635074337417744
Tax burden factor: 0.8004304108190219
ROE archetype: Standard Business
DuPont ROE decomposition for CDT (quarterly period ending 2024-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CDT (quarterly period ending 2025-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CDT (quarterly period ending 2025-06-30)
ROE: -193.95109395109395%
Asset turnover: 0
Equity multiplier (leverage): 2.462998712998713
ROE archetype: Low Return
DuPont ROE decomposition for CDT (quarterly period ending 2025-09-30)
ROE: -182.34917381836812%
Asset turnover: 0
Equity multiplier (leverage): 2.1187395926732417
ROE archetype: Low Return
DuPont ROE decomposition for CDT (quarterly period ending 2025-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CDT (quarterly period ending 2026-03-31)
ROE: -8.266094158586094%
Asset turnover: 0
Equity multiplier (leverage): 1.3505865833680977
ROE archetype: Low Return
DuPont ROE decomposition for CDZI (quarterly period ending 2025-03-31)
ROE: -21.784943794708756%
Net margin: -324.7461069735951%
Asset turnover: 0.020291806341704677
Equity multiplier (leverage): 3.3059157488361532
EBIT margin: -255.01015572105618%
ROE archetype: Low Return
DuPont ROE decomposition for CDZI (quarterly period ending 2025-06-30)
ROE: -19.421866559465332%
Net margin: -187.34852157052836%
Asset turnover: 0.02926708162650068
Equity multiplier (leverage): 3.5421037424152964
EBIT margin: -140.0145419292293%
ROE archetype: Low Return
DuPont ROE decomposition for CDZI (quarterly period ending 2025-09-30)
ROE: -22.34474478269799%
Net margin: -170.45071101470234%
Asset turnover: 0.03138604686347561
Equity multiplier (leverage): 4.176764245880662
EBIT margin: -118.00433839479392%
ROE archetype: Low Return
DuPont ROE decomposition for CDZI (quarterly period ending 2025-12-31)
ROE: -38.26707721273216%
Net margin: -191.8961447678993%
Asset turnover: 0.03781050126431652
Equity multiplier (leverage): 5.274078722861794
EBIT margin: -145.39732494099133%
ROE archetype: Low Return
DuPont ROE decomposition for CDZI (quarterly period ending 2026-03-31)
ROE: -44.43758361634249%
Net margin: -529.1666666666667%
Asset turnover: 0.011371475156253266
Equity multiplier (leverage): 7.384841000308738
EBIT margin: -418.811274509804%
ROE archetype: Low Return
DuPont ROE decomposition for CEAB3.SA (quarterly period ending 2024-12-31)
ROE: 7.705816070664303%
Net margin: 9.989608606518836%
Asset turnover: 0.25384301155203565
Equity multiplier (leverage): 3.038819847616192
EBIT margin: 18.201160450638532%
Interest burden factor: 0.6589855203503016
Tax burden factor: 0.8328629111294054
ROE archetype: Standard Business
DuPont ROE decomposition for CEAB3.SA (quarterly period ending 2025-03-31)
ROE: 0.12839196950702503%
Net margin: 0.2527166732213374%
Asset turnover: 0.17286421527012613
Equity multiplier (leverage): 2.938995127333495
EBIT margin: 7.094490230645836%
Interest burden factor: -0.02969336096319807
ROE archetype: Low Return
DuPont ROE decomposition for CEAB3.SA (quarterly period ending 2025-06-30)
ROE: 6.107433495116855%
Net margin: 9.731192642277271%
Asset turnover: 0.23260053777097617
Equity multiplier (leverage): 2.6982486098948617
EBIT margin: 20.37554233425619%
Interest burden factor: 0.6966570741232598
Tax burden factor: 0.6855479578636111
ROE archetype: Standard Business
DuPont ROE decomposition for CEAB3.SA (quarterly period ending 2025-12-31)
ROE: 8.74614288989167%
Net margin: 12.673494225490703%
Asset turnover: 0.27177029136538033
Equity multiplier (leverage): 2.5393245830579496
EBIT margin: 21.416988192034804%
Interest burden factor: 0.6819897531228037
Tax burden factor: 0.867681073908792
ROE archetype: Standard Business
DuPont ROE decomposition for CEAB3.SA (quarterly period ending 2026-03-31)
ROE: 0.04583349319086337%
Net margin: 0.10274382826961857%
Asset turnover: 0.184310089860913
Equity multiplier (leverage): 2.4203496156937856
EBIT margin: 6.098068490122638%
Interest burden factor: -0.08473906968267148
ROE archetype: Low Return
DuPont ROE decomposition for CEE (quarterly period ending 2024-10-31)
Equity multiplier (leverage): 1.0152560462740596
ROE archetype: Standard Business
DuPont ROE decomposition for CEE (quarterly period ending 2025-04-30)
Equity multiplier (leverage): 1.0485938008964293
ROE archetype: Standard Business
DuPont ROE decomposition for CEE (quarterly period ending 2025-10-31)
Equity multiplier (leverage): 1.0733093235892244
ROE archetype: Standard Business
DuPont ROE decomposition for CEI.V (annual period ending 2022-12-31)
ROE: -11.49911925584845%
Net margin: -142.5124473381846%
Asset turnover: 0.06869305176753282
Equity multiplier (leverage): 1.174624267334178
EBIT margin: -168.13481424741482%
ROE archetype: Low Return
DuPont ROE decomposition for CEI.V (annual period ending 2023-12-31)
ROE: -4.928380019068963%
Net margin: -98.64925709140027%
Asset turnover: 0.041686843007656904
Equity multiplier (leverage): 1.1984263859594029
EBIT margin: -139.14152784031216%
ROE archetype: Low Return
DuPont ROE decomposition for CEI.V (annual period ending 2024-12-31)
ROE: -5.0134594321094035%
Net margin: -64.77140361094933%
Asset turnover: 0.0625147675740294
Equity multiplier (leverage): 1.2381451928167837
EBIT margin: -70.12230634828188%
ROE archetype: Low Return
DuPont ROE decomposition for CEI.V (annual period ending 2025-12-31)
ROE: -6.825536461582639%
Net margin: -36.1876005119958%
Asset turnover: 0.12698079489454708
Equity multiplier (leverage): 1.4853847547602184
EBIT margin: -20.847418687846663%
ROE archetype: Low Return
DuPont ROE decomposition for CELEBRITY.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 5.888888888888889
ROE archetype: Standard Business
DuPont ROE decomposition for CELEBRITY.NS (quarterly period ending 2025-03-31)
ROE: -10.177095874623115%
Net margin: -4.17394680644535%
Asset turnover: 0.37485109324845317
Equity multiplier (leverage): 6.504563743195546
EBIT margin: -1.8831294894195303%
ROE archetype: Low Return
DuPont ROE decomposition for CELEBRITY.NS (quarterly period ending 2025-06-30)
Net margin: -16.547823948856653%
EBIT margin: -13.154659454143102%
ROE archetype: Standard Business
DuPont ROE decomposition for CELEBRITY.NS (quarterly period ending 2025-09-30)
ROE: -40.02026342451873%
Net margin: -9.289746001881467%
Asset turnover: 0.38486603910209993
Equity multiplier (leverage): 11.193515704153999
EBIT margin: -6.138287864534337%
ROE archetype: Low Return
DuPont ROE decomposition for CELEBRITY.NS (quarterly period ending 2025-12-31)
Net margin: -7.536359629792859%
EBIT margin: -3.856324371970031%
ROE archetype: Standard Business
DuPont ROE decomposition for CELEBRITY.NS (quarterly period ending 2026-03-31)
ROE: -16.83991683991683%
Net margin: -3.7249942515520806%
Asset turnover: 0.3896953405017921
Equity multiplier (leverage): 11.600831600831595
EBIT margin: 10.807082087836282%
Interest burden factor: -0.34468085106382984
ROE archetype: Low Return
DuPont ROE decomposition for CELZ (quarterly period ending 2025-03-31)
ROE: -20.321547740341728%
Net margin: -54603.23333333333%
Asset turnover: 0.00035939876898733646
Equity multiplier (leverage): 1.0355279760155427
EBIT margin: -55349.26666666666%
ROE archetype: Low Return
DuPont ROE decomposition for CELZ (quarterly period ending 2025-06-30)
ROE: -16.567221711349674%
Asset turnover: 0
Equity multiplier (leverage): 1.037883742393695
ROE archetype: Low Return
DuPont ROE decomposition for CELZ (quarterly period ending 2025-09-30)
ROE: -19.903546386194186%
Asset turnover: 0
Equity multiplier (leverage): 1.0434001807196804
ROE archetype: Low Return
DuPont ROE decomposition for CELZ (quarterly period ending 2025-12-31)
ROE: -28.783646601422124%
Net margin: -62922.46666666666%
Asset turnover: 0.00043915737995193864
Equity multiplier (leverage): 1.041645373178935
EBIT margin: -64859.40000000001%
ROE archetype: Low Return
DuPont ROE decomposition for CELZ (quarterly period ending 2026-03-31)
ROE: -20.555877680463432%
Asset turnover: 0
Equity multiplier (leverage): 1.0433846482094586
ROE archetype: Low Return
DuPont ROE decomposition for CEMPRO.NS (annual period ending 2023-03-31)
ROE: 10.046615037215831%
Net margin: 2.4503449440913116%
Asset turnover: 1.0146854651528556
Equity multiplier (leverage): 4.0407417616186
EBIT margin: 6.249540170480868%
Interest burden factor: 0.5780185229078111
Tax burden factor: 0.6783243481065219
ROE archetype: Standard Business
DuPont ROE decomposition for CEMPRO.NS (annual period ending 2024-03-31)
ROE: 19.874727664692433%
Net margin: 3.552841574313796%
Asset turnover: 1.4015455176288796
Equity multiplier (leverage): 3.991334604750202
EBIT margin: 7.690557088712271%
Interest burden factor: 0.6453916327425674
Tax burden factor: 0.7158049727968588
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CEMPRO.NS (annual period ending 2025-03-31)
ROE: 22.122516352560893%
Net margin: 4.031727765904981%
Asset turnover: 1.5511935769513805
Equity multiplier (leverage): 3.537344254442648
EBIT margin: 7.28107668480753%
Interest burden factor: 0.7545676004872107
Tax burden factor: 0.7338333431760469
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CEMPRO.NS (annual period ending 2026-03-31)
ROE: 27.034378589565673%
Net margin: 5.941307558808736%
Asset turnover: 1.485907301475287
Equity multiplier (leverage): 3.062264078037146
EBIT margin: 8.531714871309607%
Interest burden factor: 0.952559591770161
Tax burden factor: 0.7310608840292556
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CENN (annual period ending 2022-12-31)
ROE: -64.0459244016567%
Net margin: -1231.1593873069678%
Asset turnover: 0.033383950788027354
Equity multiplier (leverage): 1.5582584335821168
EBIT margin: -583.8959452953449%
ROE archetype: Low Return
DuPont ROE decomposition for CENN (annual period ending 2023-12-31)
ROE: -36.90107754224502%
Net margin: -519.8647394855327%
Asset turnover: 0.04599018039155334
Equity multiplier (leverage): 1.5434180438868959
EBIT margin: -414.78898360285905%
ROE archetype: Low Return